Works Cited

1. Centers for Disease Control and Prevention. 2014 National Diabetes Statistics Report. Available at http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html. Last accessed May 3, 2016.

2. Centers for Disease Control and Prevention. 2011 National Diabetes Fact Sheet. Available at http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Last accessed May 3, 2016.

3. Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.

4. International Diabetes Federation. About Diabetes. Available at http://www.idf.org/about-diabetes. Last accessed May 3, 2016.

5. Diabetes Pro. Fast Facts: Data and Statistics About Diabetes. Available at http://professional.diabetes.org/content/fast-facts-data-and-statistics-about-diabetes/?loc=dorg_statistics. Last accessed May 3, 2016.

6. Goldstein BJ, Müller-Wieland D (eds). Type 2 Diabetes: Principles and Practice. 2nd ed. New York, NY: Informa Healthcare; 2008.

7. Centers for Disease Control and Prevention. Diagnosed Diabetes. Available at http://gis.cdc.gov/grasp/diabetes/DiabetesAtlas.html. Last accessed May 3, 2016.

8. Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/northern Kentucky stroke study. Diabetes Care. 2005;28(2):355-359.

9. Centers for Disease Control and Prevention. Diabetes Public Health Resource. Age-Adjusted Percentage of People with Diabetes Aged 35 Years or Older Reporting Heart Disease or Stroke, by Race/Ethnicity, United States, 1997–2011. Available at http://www.cdc.gov/diabetes/statistics/cvd/fig6.htm. Last accessed May 3, 2016.

10. American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32(Suppl 1):S13-S61.

11. Childs BP, Cypress M, Spollett G (eds). Complete Nurse's Guide to Diabetes Care. 2nd ed. Alexandria, VA: American Diabetes Association; 2009.

12. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2016;39(Suppl 1):S1-S106.

13. Westerfield J, Holcomb S, Jensen S (eds). Current Trends in Diabetes Management: A Guide for the Healthcare Professional. 7th ed. Nashville, TN: Healthways; 2008.

14. Southerland JH, Taylor GW, Offenbacher S. Diabetes and periodontal infection: making the connection. Diabetes Care. 2005;23(4):171-178.

15. Madhu SV. Endothelial dysfunction and diabetes. JAPI. 2010;58:475-476.

16. Lorber D. Macrovascular disease in diabetes. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. Chicago, IL: American Association of Diabetes Educators; 2006: 475-510.

17. Air EL, Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care. 2007;30(12):3131-3140.

18. Boss BJ, Huether SE. Alterations in neuromotor function. In: Huether SE, McCance KL (eds). Understanding Pathophysiology. 5th ed. St. Louis, MO: Mosby; 2012: 364-371.

19. Centers for Disease Control and Prevention. Stroke Facts. Available at http://www.cdc.gov/stroke/facts.htm. Last accessed May 3, 2016.

20. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43-53.

21. Hyvärinen M, Tuomilehto J, Mähönen M, et al. Hyperglycemia and incidence of ischemic and hemorrhagic stroke: comparison between fasting and 2-hour glucose criteria. Stroke. 2009;40(5):1633-1637.

22. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30(12):2513-2516.

23. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German Stroke Data Bank. Stroke. 2001;32(11):2559-2566.

24. Frishman W, Ismail A. Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target? Cardiol Rev. 2002;10(4):199-210.

25. Adams H Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Circulation. 2007;115(20):e478-e534.

26. Donnan G, Norrving B, Bamford J, Bogousslavsky J. Classification of subcortical infarcts. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J (eds). Subcortical Stroke. 2nd ed. Oxford: Oxford Medical Publications; 2002: 27-34.

27. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6(7):611-619.

28. Bokura H, Kobayashi S, Yamaguchi S, et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis. 2006;15(2):57-63.

29. Tuttolomondo A, Pinto A, Salemi G, et al. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutr Metab Cardiovasc Dis. 2008;18(2):152-157.

30. Olsen TS. Regional cerebral blood flow after occlusion of the middle cerebral artery. Acta Neurol Scand. 1986;73(4):321-337.

31. Venes D (ed). Taber's Cyclopedic Medical Dictionary. 22nd ed. Philadelphia, PA: FA Davis Company; 2013.

32. Jauch EC. Ischemic Stroke Treatment and Management: Mechanical Thrombectomy. Available at http://emedicine.medscape.com/article/1916852-treatment#d15. Last accessed May 3, 2016.

33. National Institute of Neurological Disorders and Stroke. Transient Ischemic Attack Information Page. Available at http://www.ninds.nih.gov/disorders/tia/tia.htm. Last accessed May 3, 2016.

34. Hewko C. Acute ischemic stroke: swift assessment and quick action produce optimal outcomes. JAAPA. 2004;17(7):19-25.

35. Savitz SI, Caplan LR. Vertebrobasilar disease. N Engl J Med. 2005;352(25):2618-2626.

36. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947.

37. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-1329.

38. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40(8):2945-2948.

39. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372(9646):1303-1309.

40. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929-1935.

41. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28(11):2109-2118.

42. Diedler J, Ahmed N, Sykora M, et al. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke. 2010;(2):288-294.

43. Xian Y, Federspiel JJ, Grau-Sepulveda M, et al. Risks and benefits associated with prestroke antiplatelet therapy among patients with acute ischemic stroke treated with intravenous tissue plasminogen activator. JAMA Neurol. 2016;73(1):50-59.

44. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587.

45. Kwiatkowski TG, Libman RB, Frankel M, et al. for the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med. 1999;340(23):1781-1787.

46. Lyden PD. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Humana Press; 2005.

47. National Stroke Association. Stroke Treatments. Available at http://www.stroke.org/site/PageServer?pagename=treatment. Last accessed May 3, 2016.

48. Lutsep HL. Mechanical Thrombolysis in Acute Stroke. Available at http://emedicine.medscape.com/article/1163240-overview#a1. Last accessed May 3, 2016.

49. Powers WJ, Derdeyn CP, Biller J, et al. 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020-3035.

50. Hassan AE, Aman MM, Chauhdry SA, et al. Value of other endovascular techniques among patients with MERCI device failure during the treatment of acute ischemic stroke: what to do when MERCI fails? J Vasc Interv Neurol. 2013;5(2):27-31.

51. Jeffrey S. Solitaire Device for Stroke Gets FDA Nod. Available at http://www.medscape.com/viewarticle/759773. Last accessed May 3, 2016.

52. Kent C. Stryker Receives FDA Approval for its Trevo Pro Retriever Mechanical Thrombectomy Device. Available at https://www.advisory.com/research/service-line-strategy-advisor/the-pipeline/2012/08/stryker-receives-fda-approval-for-its-trevo-pro-retriever-mechanical-thrombectomy-device. Last accessed May 3, 2016.

53. Chinese Acute Stroke Trial (CAST) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349(9066):1641-1649.

54. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569-1581.

55. Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;3:CD000029.

56. Lapchak PA, Araujo DM. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke. Am J Cardiovasc Drugs. 2003;3(2):87-94.

57. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke. 2005;36(4):880-890.

58. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517-584.

59. Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754-3832.

60. Bloomgarden ZT. Inpatient diabetes control: approaches to treatment. Diabetes Care. 2004;27(9):2272-2277.

61. Müller-Nordhorn J, Nolte CH, Rossnagel K, et al. Knowledge about risk factors for stroke: a population-based survey with 28,090 participants. Stroke. 2006;37(4):946-950.

62. Schneider AT, Pancioli AM, Khoury JC, et al. Trends in community knowledge of the warning signs and risk factors for stroke. JAMA. 2003;289(3):343-346.

63. Rosamond WD, Gorton RA, Hinn AR, Hohenhaus SM, Morris DL. Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. Acad Emerg Med. 1998;5(1):45-51.

64. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569-1581.

65. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005;64(4):654-659.

66. Wattigney WA, Croft JB, Mensah GA, et al. Establishing data elements for the Paul Coverdell National Acute Stroke Registry. Part 1: proceedings of an expert panel. Stroke. 2003;34(1):151-156.

67. Kothari R, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med. 1999;33(4):373-378.

68. Kleindorfer D, Miller R, Moomaw CJ, et al. Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke. 2007;38(10):2864-2868.

Evidence-Based Practice Recommendations Citations

1. University of Michigan Health System. Secondary Prevention of Ischemic Heart Disease and Stroke in Adults. Ann Arbor, MI: University of Michigan Health System; 2014. Summary retrieved from National Guideline Clearinghouse at http://www.guideline.gov/content.aspx?id=48221. Last accessed May 10, 2016.


Copyright © 2016 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.